6 January 2016
UK researchers are carrying out a study to assess whether physical exercise could be introduced as a new NHS treatment for prostate cancer.
The PANTERA study, led by Sheffield Hallam University and backed by Cancer Research UK, aims to build on the current understanding that men who are physically active after a prostate cancer diagnosis generally have better cancer survival rates.
Half of the participants will take part in two-and-a-half hours of aerobic exercise every week for 12 months, while the remainder will be given information about the benefits of exercise, but will have no supervised sessions.
This trial is believed to be the first of its kind in the world and could lead to a full-scale study looking at the potential benefits of combining active surveillance and exercise for prostate cancer patients.
Study leader Dr Liam Bourke, principal research fellow at Sheffield Hallam University, said: "If we show it works and is feasible, it could be a real leap forward and good news for cancer patients."
A total of 50 men will be enrolled in the study who have prostate cancer that has not yet spread.
Posted by Philip Briggs
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.